CANbridge Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1.96	10.5	137.49	463.11	745.82	360.8
Cash & Short-Term Investments	1.96	10.5	137.49	463.11	745.82	360.8
Cash Growth	-96.01%	-92.36%	-70.31%	-37.91%	106.71%	2500.76%
Accounts Receivable	7.17	16.72	31.23	19.05	9.14	7.04
Other Receivables	-	9.87	8.29	-	18.76	8.77
Receivables	7.17	26.59	39.52	19.05	27.9	25.01
Inventory	24.69	7.9	8.78	9.82	13.45	0.55
Other Current Assets	9.66	0.36	24.08	13.18	24.54	4.68
Total Current Assets	43.48	45.35	209.86	505.16	811.71	391.05
Property, Plant & Equipment	0.73	3.64	109.01	144.72	29.54	15.57
Other Intangible Assets	61.29	67.82	76.49	49.01	51.27	179.74
Other Long-Term Assets	-	-	-	3.16	-	-
Total Assets	105.5	116.81	395.36	702.05	892.52	586.36
Accounts Payable	392.95	370.46	198.05	107.54	43.61	46.71
Accrued Expenses	-	68.7	63.46	114.98	93.82	23.91
Current Portion of Long-Term Debt	24.17	15.33	23.69	26.87	30.87	22.31
Current Portion of Leases	2.37	11.76	11.03	13.03	7.88	5.52
Other Current Liabilities	86.67	16.37	31.71	15.69	9.6	9.65
Total Current Liabilities	506.16	482.61	327.95	278.11	185.78	108.1
Long-Term Debt	8	15.04	6.63	10.78	-	2,179
Long-Term Leases	0.42	93.65	100.58	104.61	13.35	7.42
Other Long-Term Liabilities	-	-	-	-	-	37.93
Total Liabilities	514.58	591.3	435.15	393.49	199.13	2,332
Common Stock	0.03	0.03	0.03	0.03	0.03	0.01
Additional Paid-In Capital	3,474	3,474	3,473	3,471	3,471	26.36
Retained Earnings	-4,147	-4,210	-3,789	-3,411	-2,927	-1,850
Comprehensive Income & Other	263.63	261.79	276.55	247.88	149.89	77.9
Shareholders' Equity	-409.08	-474.49	-39.79	308.56	693.39	-1,746
Total Liabilities & Equity	105.5	116.81	395.36	702.05	892.52	586.36
Total Debt	34.97	135.78	141.93	155.28	52.1	2,214
Net Cash (Debt)	-33.01	-125.28	-4.44	307.83	693.71	-1,853
Net Cash Growth	-	-	-	-55.63%	-	-
Net Cash Per Share	-0.08	-0.29	-0.01	0.73	7.36	-27.02
Filing Date Shares Outstanding	424.84	424.56	424.56	424.29	424.19	469.11
Total Common Shares Outstanding	424.84	424.56	424.56	424.29	424.19	73.56
Working Capital	-462.68	-437.26	-118.08	227.06	625.93	282.94
Book Value Per Share	-0.96	-1.12	-0.09	0.73	1.63	-23.73
Tangible Book Value	-470.37	-542.31	-116.28	259.54	642.12	-1,926
Tangible Book Value Per Share	-1.11	-1.28	-0.27	0.61	1.51	-26.18
Machinery	-	10.68	16.58	13.54	4.79	3.75
Leasehold Improvements	-	1.94	3.94	10.86	11.32	5.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.